Discriminative use of SPECT in frontal lobe-type dementia versus (senile) dementia of the Alzheimer's type

Journal of Nuclear Medicine

Volumn 38, Issue 6, 1997, Pages 929-934

  Pickut, Barbara A ^b   Saerens, Jos ^b   Mariën, Peter ^b   Borggreve, Fons ^b   Goeman, Johan ^b   Vandevivere, Johan ^b   Vervaet, An ^b   Dierckx, Rudi ^b   De Deyn, Peter P ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b NONE

Author keywords

Alzheimer's disease; Brain perfusion; Dementia; SPECT

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; CLINICAL ARTICLE; COMPARATIVE STUDY; DEMENTIA; DISCRIMINANT ANALYSIS; FEMALE; FRONTAL LOBE; HUMAN; MALE; PREDICTION; PRIORITY JOURNAL; SENILE DEMENTIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; ALZHEIMER DISEASE; BRAIN; CEREBROVASCULAR CIRCULATION; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LOGISTIC MODELS; MALE; ORGANOTECHNETIUM COMPOUNDS; OXIMES; PREDICTIVE VALUE OF TESTS; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030915327     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Gustafson L. Clinical picture of frontal lobe degenerations of the non-Alzheimer type. Dementia 1993;4:143-148.
2. Neary D. Dementia of frontal lobe type. J Am Ger Soc 1990;38:71-72.
3. Gustafson L. Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis. Arch Gerontol Geriatr 1987;6:209-223.
4. Brun A. Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology. Arch Gerontol Geriatr 1987;6:193-208.
5. Englund E, Brun A. Frontal lobe degeneration of non-Alzheimer type. IV. White matter changes. Arch Gerontol Geriatr 1987;6:235-244.
6. Risberg J. Frontal lobe degeneration of non-Alzheimer type. III Regional cerebral blood flow. Arch Gerontol Geriatr 1987;6:225-233.
7. Brun A. Dementia of frontal type. Dementia 1993;4:125.
8. Knopman DS. Overview of dementia lacking distinctive histology: pathological designation of a progressive dementia. Dementia 1993;4:132-136.
9. Miller BL, Cummings JL, Villanueva-Meyer J, et al. Frontal lobe degeneration: clinical, neuropsychologica, and SPECT characteristics. Neurology 1991;41:1347-1382.
10. Goulding P, Burjan A, Smith R, et al. Semi-automatic quantification of regional cerebral perfusion in primary degenerative dementia using technetium-99m-hexamethylproylene amine oxime and single photon emission tomography. Eur J Nucl Med 1990;17:77-82.
11. Neary D, Snowden JS, Northen B, Goulding P. Dementia of the frontal lobe type. J Neurol Neurosurg Psych 1988;51:353-361.
12. Ohnishi T, Hoshi H, Jinnouchi S, Nagamachi S, Watanabe K, Mituyama Y. The utility of cerebral blood flow imaging in patients with unique syndrome of progressive dementia with motor neuron disease. J Nucl Med 1990;31:688-691.
13. Risberg J, Passant U, Warkentin S, Gustafson L. Regional blood flow in frontal lobe dementia of non-Alzheimer type. Dementia 1993;4:186-187.
14. Van Heertum RL. Clinical diagnosis: major depressive disorder. In: Van Heertum RL, Tikofsky RS, eds. Cerebral SPECT imaging, 2nd ed. New York: Raven Press; 1995:194.
15. Pohl P, Vogel G, Fill H, Rössler H, Zangerle R, Gerstenbrand F. Single-photon emission computed tomography in AIDS dementia complex. J Nucl Med 1988;29: 1382-1386.
16. 99mTc-HMPAO in patients with dementia (Alzheimer type and HIV) and Parkinson's disease-initial results. J Cereb Blood Flow Metab 1988;8:S109-S115.
17. Neary D, Snowden JS, Mann DMA. The clinical pathological correlates of lobar atrophy. Dementia 1993;4:143-149.
18. 123I-AMP) in normal pressure hydrocephalus (NPH). Eur J Nucl Med 1988;14:73-79.
19. Cole MG, Dastoor D. A new hierarchic approach to the measurement of dementia. Psychosomatics 1987;28:298-305.
20. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurol 1984;34:939-944.
21. Holman BL, Johnson KA, Greada B, Carvalho PA, Smith A. The Scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT. J Nucl Med 1992;33:1941-185.
22. Johnson KA, Holman BL, Mueller SP, et al. Single-photon emission computed tomography in Alzheimer's disease. Abnormal I-123-iofetamine uptake reflects dementia severity. Arch Neurol 1988:45-392-396.
23. Eagger S, Syed GMS, Burns A, Barette JJ, Levy R. Morphologic (CT), and functional (rCBF SPECT) correlates m Alzheimer's disease. Nucl Med Commun 1992;13:644-647.
24. Wolfe N, Reed BR, Eberling JL, Jagust WJ. Temporal lobe perfusion on single-photon emission computed tomography predicts the rate of cognitive decline in Alzheimer's disease. Arch Neurol 1995;52:257-262.
25. Perani D, DiPiero V, Vallar G, et al. Technetium-99m-HMPAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease. J Nucl Med 1988;29:1507-1514.
26. McGeer PL, Kamo H, Harrop R, et. al Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease. Neurol 1986;36:1569-1574.
27. Jobst KA, Smith AD, Barker CS, et al. Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease. J Neurol Neurosurg Psych 1992;55:190-194.
28. Launes J, Sulkava R, Erkinjuntti T, et al. Technetium-99m-HMPAO SPECT in suspected dementia. Nucl Med Commun 1991;12:757-765.